NCT05017974

Brief Summary

The overarching goal is to utilize a randomized control design to examine acceptability, feasibility, and adherence of mindfulness-based stress reduction plus prenatal sleep supplement (MBSR+PS) compared to treatment as usual among pregnant people with poor sleep quality (n=50).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 24, 2021

Completed
15 days until next milestone

Study Start

First participant enrolled

September 8, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 29, 2022

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 14, 2022

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

November 18, 2023

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

10 months

First QC Date

August 17, 2021

Results QC Date

June 6, 2023

Last Update Submit

November 15, 2023

Conditions

Keywords

pregnancysleepmindfulness

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With a Total Score Greater Than or Equal to 24 on the 8-item Client Satisfaction Questionnaire (CSQ-8) at 12 Weeks

    The Client Satisfaction Questionnaire (CSQ-8) score ranges from 8 to 32, with high scores indicating greater satisfaction. The CSQ-8 score of participants randomized to MBSR+PS will be reported; participants randomized to TAU will not complete the CSQ-8 as the questions pertain to the MBSR+PS program.

    Post-intervention, an average of 12 weeks

Secondary Outcomes (18)

  • Number of Participants Who Attend at Least One Session of MBSR and the PS Supplement From Baseline to 12 Weeks

    Baseline to post-intervention, an average of 12 weeks

  • Number of Participants Completing Endpoint Measures at 12 Weeks

    Post-intervention, an average of 12 weeks

  • Completeness of Study Measures at Baseline and at 12 Weeks

    Baseline and post-intervention, an average of 12 weeks

  • Percentage of MBSR and PS Sessions Attended

    Baseline to post-intervention, an average of 12 weeks

  • Frequency of Home Practices From Baseline to 12 Weeks

    Baseline to post-intervention, an average of 12 weeks

  • +13 more secondary outcomes

Study Arms (2)

Mindfulness-Based Stress Reduction plus Prenatal Sleep supplement (MBSR+PS)

EXPERIMENTAL

The study intervention is standard mindfulness-based stress reduction (MBSR), which will be delivered through 8 weekly 2.5-hour sessions via video conferencing to groups of 20-30 pregnant and non-pregnant people. MBSR also consists of a 2.5-hour orientation session, a 30-minute private interview with the instructor, and an all-day retreat, all conducted via video conferencing. The supplemental prenatal sleep content will be delivered through 6-8 30-minute sessions via video conferencing either individually or to small groups, and draws material from mindfulness-based therapy for insomnia, mindfulness-based childbirth and parenting program, and cognitive behavior therapy for prenatal insomnia.

Behavioral: Mindfulness-Based Stress Reduction plus Prenatal Sleep supplementOther: Treatment as Usual

Treatment as Usual

OTHER

The control condition was designed to reflect standard care for insomnia patients. No limits are placed on receiving non-study treatment, including medication or psychotherapy, with the exception of asking participants to refrain from participating in non-study mindfulness practice. Use of non-study treatment will be tracked.

Other: Treatment as Usual

Interventions

MBSR+PS

Mindfulness-Based Stress Reduction plus Prenatal Sleep supplement (MBSR+PS)

TAU

Mindfulness-Based Stress Reduction plus Prenatal Sleep supplement (MBSR+PS)Treatment as Usual

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnancy 12-28 weeks gestation at time of intervention start
  • years of age or older
  • Regular access to a web-enabled computer, phone or tablet
  • Ability to read and speak English, and to provide informed consent
  • Poor sleep quality (PSQI \> 5)

You may not qualify if:

  • Self-reported sleep disorder (e.g. sleep apnea, narcolepsy, parasomnia, circadian rhythm disorder)
  • Shift-work or nighttime caregiving responsibilities
  • Psychological, medical, or other issues that necessitate priority treatment (e.g. active suicidality, probable depression (PHQ-9 ≥ 10), psychosis, on bed rest, multiple gestation)
  • Current regular mindfulness practice (\>20 minutes/week)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, San Francisco

San Francisco, California, 94118, United States

Location

MeSH Terms

Interventions

Mindfulness-Based Stress ReductionTherapeutics

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Results Point of Contact

Title
Dr. Jennifer Felder
Organization
University of California, San Francisco

Study Officials

  • Jennifer N Felder, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 17, 2021

First Posted

August 24, 2021

Study Start

September 8, 2021

Primary Completion

June 29, 2022

Study Completion

July 14, 2022

Last Updated

November 18, 2023

Results First Posted

November 18, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations